Our Global Vision

From its very inception C2 Capital, has had the vision of developing a market leading offering that can be taken beyond Australia to a global market.

From its very inception C2 Capital has had the vision of developing a market leading offering that can be taken beyond Australia to a global market.

This outcome has now been realised with the successful launch in May 2018 of our first international office and global headquarters in Singapore, the fourth most important financial centre in the world (behind London, New York and Hong Kong).

This gives a launch pad to focus on the ASEAN countries, China and India as we believe over the next 20 years this aspirational region will be the economic powerhouse of the world with most achieving first world status with significant middle classes that want to create greater wealth.

Imagineering Investments that make a difference.

C2 CAPITAL.

It is estimated that in the next 10 years 70% of the $100 trillion of global funds under management will be in this part of the world and as an Australian company operating in this market, we will benefit from Australia’s reputation as a financial services leader that represents 4% of the global market with a fraction of its population.

Another advantage is that the eastern seaboard of Australia is within this timezone, the extreme of New Delhi being 4.5 hours behind us which makes doing business in these high-value markets easier.

What we do

IN BRIEF – OUR REGULAR UPDATES

Any information or advice contained on this website is general in nature and has been prepared without taking into account your objectives, financial situation or needs. Before acting on any information on this website, you should consider the appropriateness of it (and any relevant product) having regard to your circumstances and, if a current offer document is available, read the offer document before acquiring products named on this website. You should also seek independent financial advice prior to acquiring a financial product. All financial product involve risks. Past performance of any product described on this site is not a reliable indication of future performance.
C2 Portfolio 1 Pty Ltd is the Trustee of the Pakenham Medical Precinct Trust. It holds a Corporate Authorised Representative authorisation from Quay Fund Services Limited (Quay) (AFSL No.494886). C2 Capital Investor Channels Pty Ltd also holds a Corporate Authorised Representative authorisation from Quay allowing it to provide General Product Advice.